Phenolic Derivatives of Astragalus aitosensis with Selective MAO-B Inhibition and Mitochondrial Protection
Molecules · 2025
DOI: 10.3390/molecules30204069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Preslav Enchev und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Mitochondria, Monoamine Oxidase, Monoamine Oxidase Inhibitors, Astragalus Plant. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was financed by the European Union-NextGenerationEU, through the National Re-covery and Resilience Plan of the Republic of Bulgaria, project BG-RRP-…, European Union, NextGenerationEU.
Abstract (Originalsprache)
Astragalus aitosensis, also known as Astracantha arnacantha (M. Bieb.) Podlech subsp. aitosensis (Ivanisch.) Réer & Podlech, a Bulgarian endemic species, was investigated for its phenolic profile and neuroprotective potential. A targeted extraction approach led to the isolation of 14 phytochemicals. According to our literature review, none of the isolated chemicals have been reported before for A. aitosensis. Two of them are previously undescribed molecules—an isomer of odoratin and 6-hydroxy-3-(2-hydroxy-4-methoxyphenyl)-7-methoxy-4H-1-benzopyran-4-one—and four of them had not been observed before our study in the genus Astragalus: 3′-methoxydaidzein, fujikinetin, sayanedine, and 6,4′-dimethoxy-7,2′-dihydroxyisoflavone. Five of the phytochemicals—maackiain, cajanin, onogenin, afrormosin, and sayanedine—exhibited selective inhibition of human monoamine oxidase-B (MAO-B), with maackiain reducing activity by 45%, nearing the effect of selegiline. The investigated phytochemicals also showed significant antioxidant and neuroprotective effects in ex vivo models using isolated rat brain synaptosomes, mitochondria, and microsomes, mitigating oxidative stress by preserving glutathione levels and reducing lipid peroxidation. Molecular docking confirmed favorable binding of active phytochemicals, particularly maackiain, within the MAO-B active site. Structure–activity relationship (SAR) analysis highlighted the role of specific substituents and fused-ring systems in MAO-B inhibition. This study expands our knowledge of the phytochemical diversity of A. aitosensis and supports the therapeutic relevance of its phenolic compounds in neurodegenerative disorders such as Parkinson’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria.
- Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria.
ORCID-Profile: Preslav Enchev, Emilio Mateev, Yancho Zarev
Förderung
- This study was financed by the European Union-NextGenerationEU, through the National Re-covery and Resilience Plan of the Republic of Bulgaria, project BG-RRP-…
- European Union, NextGenerationEU
Zitieren
APA
Enchev, P., Kondeva-Burdina, M., Mateev, E., Ionkova, I., & Zarev, Y. (2025). Phenolic Derivatives of Astragalus aitosensis with Selective MAO-B Inhibition and Mitochondrial Protection. Molecules. https://doi.org/10.3390/molecules30204069
Vancouver
Enchev P, Kondeva-Burdina M, Mateev E, Ionkova I, Zarev Y. Phenolic Derivatives of Astragalus aitosensis with Selective MAO-B Inhibition and Mitochondrial Protection. Molecules. 2025. doi:10.3390/molecules30204069
BibTeX
@article{Enchev2025,
author = {Enchev, Preslav and Kondeva-Burdina, Magdalena and Mateev, Emilio and Ionkova, Iliana and Zarev, Yancho},
title = {Phenolic Derivatives of Astragalus aitosensis with Selective MAO-B Inhibition and Mitochondrial Protection},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30204069}
}
EUVIMED